Nine U of A students, the largest group ever, shared their STEM research with elected officials, educators, peers and fellow presenting students from 13 Arkansas institutions.
Analyst Gil Blum of Needham maintained a Buy rating on Nurix Therapeutics (NRIX – Research Report), reducing the price target to $28.00.Invest ...
Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications. Market Capitalization Perspectives: The company's market ...
Reported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL at the 66th ...
Here we explore peptide inhibitors of Cdc20, a substrate-recognition subunit and activator of the E3 ubiquitin ligase the anaphase promoting complex/cyclosome (APC/C) that is essential in mitosis and ...
Story continues below this ad According to market participants, by launching the “when-listed” platform, SEBI wants to ensure some amount of pre-IPO activity to happen, but in a legal manner. The SEBI ...
second that the essential roles of TRAF6 in initiating innate immune signalling are independent of its E3 ligase activity; third that the HOIL-1 component of the Linear Ubiquitin Assembly Complex ...
So, how might you join in the festivities with your family this weekend? We have some fun activity ideas for you to try at home, with advice from Janet Cooper, a speech and language therapist ...
These first-in-class compounds restore the enzyme’s activity to levels comparable to those of youthful cells, offering substantial potential for clinical applications in treating age-related disorders ...
Seven adventure training centres have closed after the firm that ran them went into administration Seven residential activity centres for schools have closed after the company that ran them went ...
Seven residential activity centres for schools have closed after the company that ran them went in administration. The Inspiring Learning Group said the centres - operated by its subsidiary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results